You searched for "tumour"
PET imaging of prostate-specific membrane antigen in prostate cancer
Molecular imaging utilising prostate-specific membrane antigen (PSMA) as a target has increasingly been mentioned at key conferences and meetings. PSMA is a membrane metalloenzyme that is overexpressed in prostate cancer, with the degree of expression appears to correlate with tumour...de smit medical: An introduction to biofeedback and electrical stimulation for adult pelvic floor muscle dysfunction Sep 25
Course tutor: Julia Herbert, Grad Dip Phys., MSc. MCSP, MPOGP. Consultant Physiotherapist Pelvic Health This 1 day introductory course will provide qualified healthcare practitioners with an introduction to using pelvic floor muscle neuromuscular electrical stimulation (NMES) and biofeedback.de smit medical: An introduction to biofeedback and electrical stimulation for adult pelvic floor muscle dysfunction (Mar 25)
Course tutor: Julia Herbert, Grad Dip Phys., MSc. MCSP, MPOGP. Consultant Physiotherapist Pelvic Health This 1 day introductory course will provide qualified healthcare practitioners with an introduction to using pelvic floor muscle neuromuscular electrical stimulation (NMES) and biofeedback.Indeterminate renal lesions – a pragmatic imaging approach
The incidence of renal cell carcinoma (RCC) in the UK has increased steadily over the last two decades, largely driven by the increasing use of abdominal imaging and the incidental detection of small renal lesions [1]. The majority of incidental...Read all about it Sep/Oct 2018
For this article we are ditching the usual format and looking instead at some the standout posters and papers from the recent BAUS meeting that have the potential to inform, change and influence your practice in the near future. Whilst...Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...The role of PET-CT imaging in prostate cancer
Prostate cancer (PCa) is the second most common cancer in the UK, with 43,000 cases in 2017-18 [1,2]. Accurate primary staging and the detection of suspected recurrence following treatment is vital for directing management and predicting prognosis. This has conventionally...Demanding cases or nightmares in uro-oncology? May/Jun 2022
Delayed diagnosis of testicular cancer Testicular cancer is considered rare in the general population but is the most common cancer affecting males between 24 and 49 years. The diagnosis of testicular cancer depends on physical examination, ultrasound findings and tumour...Clinical Trials 2 – key papers
Clinical Trials 1 is available here. Case 1 This British study on haematuria clinic diagnostic yield was published in the British Journal of Urology International in 2006. The results are often asked in examinations! Edwards TJ, et al. A prospective...Read all about it Nov/Dec 2014
It can be awkward when a patient asks you about a report in their favourite tabloid detailing an amazing research breakthrough or a ‘cutting-edge’ new treatment / test and you don’t know what they are talking about! So this section...So you want to go on a Fellowship: part 1
Look out for part 2 of this series later in 2016 when the author will discuss settling into the research role of his fellowship and will reflect on his first year overseas. This is the first in a series of...
